问题 › 数字化转型咨询 › HealthTech & Digital Health
在数字健康领域，承担结果风险的合同往往在能够交付这些结果的运营模式到位前就已签署，因此平台上线后，与风险挂钩的收入份额仍保持不变。 对数字健康公司而言，问题具体表现为：承载答案的数字是与风险挂钩的收入份额和参与率，而行业特有的复杂之处在于，结果风险的签署速度快于公司验证自身能否承担该风险的速度——12个月的测量窗口对上11个月的销售周期。这个问题的通用版本与您实际面对的版本，前期动作不同。
在数字健康领域，承担结果风险的合同往往在能够交付这些结果的运营模式到位前就已签署，因此平台上线后，与风险挂钩的收入份额仍保持不变。 对数字健康公司而言，问题具体表现为：承载答案的数字是与风险挂钩的收入份额和参与率，而行业特有的复杂之处在于，结果风险的签署速度快于公司验证自身能否承担该风险的速度——12个月的测量窗口对上11个月的销售周期。这个问题的通用版本与您实际面对的版本，前期动作不同。
项目停滞是因为顺序从平台开始，而不是从产生参与率和归因结果的路径开始。当前工作流围绕例外情况和手动交接构建，直接被照原样编码。上线后系统记录相同的触点和延迟，因此注册成员的参与率没有提升，与结果挂钩的收入份额也未改善。
商业案例由第一年出现的许可和集成数字组成，而回报则体现在毛利率和PMPM上，这些只有在测量窗口结束后才显现。如果底层路径未变，成本按时到达，运营收益仍停留在无法用实际客户流失验证的预测阶段。
根本问题是技术是否让公司能够出售新的基于结果的安排，还是仅降低运行现有安排的成本。两者需要不同的预算和测试；混在一起会让案例无法区分商业收益与运营效率，CEO或CFO也无法判断。
Digital & Technology Strategy（目录编号t8）按此顺序处理问题：先映射每个流程目前消耗的与风险挂钩份额和PMPM，分离决策步骤与工具步骤，在列出供应商短名单前先明确案例是商业性质还是运营性质。如果答案是 straightforward 的实施且有可衡量的回报，就直接说明，由实施伙伴跟进。
这三者同时出现才是标志。单独一个通常指向其他问题。
✓ 已签署与风险挂钩的份额承诺，但尚未建立注册成员的基准参与率。
✓ 财务模型依赖许可费用削减，而非毛利率或客户流失的预计变化。
✓ 此前平台按时上线，但同一群体的归因结果未发生变化。
通常会让情况更糟的做法。 在映射决定结果能否归因、风险能否承担的护理路径之前，先选择平台。
It is for you if you run or finance a digital health company and a platform has been shortlisted and the target process has not been drawn. It is the situation where the numbers are available but nobody has put them in an order that produces a decision.
It is not for you if Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Below is an excerpt from a real run of this analysis on 一家数字健康公司. It is a sample profile rather than a customer, and it is engine output translated from English — this is the format you get, on your own numbers.
The subject is Vantabridge Health, a sample company profile used for testing rather than a customer — $62M ARR, 340,000 enrolled members.
Excerpt from a real Percision run · Pricing Strategy · sample company profile
The move. Convert 2.9M contracted lives into Medicare Advantage outcomes contracts using existing payer integrations and outcomes proof points.
The leak it closes. Prevents value leakage to in-house payer solutions by demonstrating superior 12-month cohort outcomes data
The assumption it rests on. At least 4 of 34 existing health plans will sign MA outcomes contracts within 24 months — the engine put the probability at 0.75.
| Investment required | $1.8-2.4M total over 24 months |
| Expected return | 250-580% over 36 months on $62M base revenue |
| Revenue, year 1 | $2-4M incremental ARR (2-3 MA contracts) |
| Revenue, year 2 | $6-14M incremental ARR (4-7 MA contracts) |
| Revenue, year 3 | $12-25M incremental ARR (8-12 MA contracts) |
| Exit criteria | Abandon if fewer than 2 MA contracts signed by month 18 OR if engagement rate in MA pilot cohort falls below 30% OR if NCQA certification denied |
This is one move out of a full analysis. Read a complete report — every page, no email required.
This question routes to Digital & Technology Strategy, one of 29 engagements the platform runs. For 数字健康公司 it works through at-risk revenue share, engagement rate, gross margin and logo churn, then produces the sequence rather than a list of options — which move first, what it funds, and the observation that would say the sequence is wrong.
You watch the analysis get built before paying anything. 在此阅读完整报告 if you would rather see the depth first.
工作不同。咨询公司用于决定应该改变什么以及商业案例是什么；集成商用于让选定的平台运行起来。用集成商回答战略问题，会得到对未审视流程的非常好的实施。用咨询公司做实施，则会得到更慢、更贵的集成商。
咨询部分在中期市场通常为八到十六周，费用£80k–£300k。后续实施通常是这个数字的五到二十倍，因此咨询阶段值得比其预算份额更多的审查——它决定了之后的一切规模。
选取一笔交易，统计手动触点数量以及各触点间的等待时间。如果大部分流逝时间是人们在等待决策或批准，那就是流程与治理问题，新系统会保留它。如果大部分时间是重新录入、对账或查询，那就是真正的工具问题，技术才能改变数字。
Materially, yes. Outcomes risk is being signed faster than the company can learn whether it can carry it — a 12-month measurement window against an 11-month sales cycle — which changes both the diagnosis and the order of the fixes. The metrics that decide it here are at-risk revenue share, engagement rate, gross margin, and an answer built on industry-general benchmarks will usually point at the wrong one first.
Less than most people expect. Your last twelve months of revenue and cost split the way you already split it, plus whatever you hold on at-risk revenue share and engagement rate. The analysis is explicit about what it is assuming where your data stops, which is more useful than waiting for numbers you may never have.
Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Describe the situation in your own words and we will tell you which analysis answers it — before you sign up for anything.
Describe my situation →Prefer to skip ahead? Go straight to the free diagnostic.
English · Español · Deutsch · Português · Français · Italiano · Nederlands · 日本語 · 한국어 · 中文 · Polski · Svenska · Türkçe · العربية · Tiếng Việt · ไทย · हिन्दी · עברית